US Patent Issued to Regeneron Pharmaceuticals on Sept. 29 for "Non-human animals having humanized Fc-gamma receptors" (New York Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,745,761, issued on Sept. 29, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Non-human animals having humanized Fc-gamma receptors" was invented by Andrew J. Murphy (Croton-On-Hudson, N.Y.), Lynn Macdonald (Harrison, N.Y.), Cagan Gurer (Chappaqua, N.Y.), Karolina A. Meagher (Yorktown Heights, N.Y.) and Naxin Tu (Pleasantville, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Genetically modified mice and methods and compositions for making and using the same are provided, wherein the genetic modification comprises humanization of an FcGammaRI protein."

The patent was filed on Oct. 17, 2022, under Application No. 17/967,510.

*For...